CIK 0001232524
- Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- EIN
- 981032470
- Phone
- +353 16347800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-27 | Mulligan Seamus Director | Purchase | +8,391 | $110.52 | $927K | 1,131,422 |
| 2020-05-27 | Mulligan Seamus Director | Purchase | +9,884 | $111.56 | $1.1M | 1,141,306 |
| 2020-05-27 | Mulligan Seamus Director | Purchase | +11,482 | $112.32 | $1.3M | 1,152,788 |
| 2020-05-26 | Mulligan Seamus Director | Purchase | +15,000 | $110.65 | $1.7M | 1,117,788 |
| 2020-05-07 | GALA RENEE D EVP & CFO | Grant or award | +16,600 | 16,600 | ||
| 2020-05-07 | GALA RENEE D EVP & CFO | Grant or award · Incentive Stock Option (right to buy) | +3,652 | 3,652 | ||
| 2020-05-07 | GALA RENEE D EVP & CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +37,848 | 37,848 | ||
| 2020-05-07 | Pearce Samantha SVP, Europe and Rest of World | Grant or award | +10,200 | 10,200 | ||
| 2020-05-07 | Pearce Samantha SVP, Europe and Rest of World | Grant or award · Non-Qualified Stock Option (right to buy) | +25,500 | 25,500 | ||
| 2020-03-12 | Carr Patricia VP, Finance & PAO | Sale | −600 | $102.17 | $61K | 6,500 |
| 2020-03-12 | MILLER MICHAEL PATRICK EVP, US Commercial | Sale | −1,500 | $102.17 | $153K | 22,118 |
| 2020-03-09 | Larkin Finbar SVP, Technical Operations | Sale | −615 | $111.49 | $69K | 13,883 |
| 2020-03-09 | Carr Patricia VP, Finance & PAO | Sale | −568 | $111.45 | $63K | 7,100 |
| 2020-03-06 | Larkin Finbar SVP, Technical Operations | Sale | −292 | $119.15 | $35K | 14,498 |
| 2020-03-06 | Carr Patricia VP, Finance & PAO | Sale | −232 | $119.17 | $28K | 7,668 |
| 2020-03-05 | Swisher Daniel N JR President and COO | Shares withheld for taxes | −1,735 | $124.50 | $216K | 43,391 |
| 2020-03-05 | MILLER MICHAEL PATRICK EVP, US Commercial | Shares withheld for taxes | −2,423 | $124.50 | $302K | 23,618 |
| 2020-03-05 | COZADD BRUCE C Chairman & CEO | Shares withheld for taxes | −15,071 | $124.50 | $1.9M | 340,033 |
| 2020-03-04 | Carr Patricia VP, Finance & PAO | Sale | −253 | $118.67 | $30K | 7,900 |
| 2020-03-03 | Larkin Finbar SVP, Technical Operations | Sale | −279 | $119.75 | $33K | 14,790 |
Page 38 of 39 · 780 trades